Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 36, No. 8 ( 2021-07-23), p. 1500-1510
    Abstract: The lack of a well-designed prospective study of the determinants of urgent dialysis start led us to investigate its individual- and provider-related factors in patients seeing nephrologists. Methods The Chronic Kidney Disease Renal Epidemiology and Information Network (CKD-REIN) is a prospective cohort study that included 3033 patients with CKD [mean age 67 years, 65% men, mean estimated glomerular filtration rate (eGFR) 32 mL/min/1.73 m2] from 40 nationally representative nephrology clinics from 2013 to 2016 who were followed annually through 2020. Urgent-start dialysis was defined as that ‘initiated imminently or & lt;48 hours after presentation to correct life-threatening manifestations’ according to the Kidney Disease: Improving Global Outcomes 2018 definition. Results Over a 4-year (interquartile range 3.0–4.8) median follow-up, 541 patients initiated dialysis with a known start status and 86 (16%) were identified with urgent starts. The 5-year risks for the competing events of urgent and non-urgent dialysis start, pre-emptive transplantation and death were 4, 17, 3 and 15%, respectively. Fluid overload, electrolytic disorders, acute kidney injury and post-surgery kidney function worsening were the reasons most frequently reported for urgent-start dialysis. Adjusted odds ratios for urgent start were significantly higher in patients living alone {2.14 [95% confidence interval (CI) 1.08–4.25] or with low health literacy [2.22 (95% CI 1.28–3.84)] , heart failure [2.60 (95% CI 1.47–4.57)] or hyperpolypharmacy [taking & gt;10 drugs; 2.14 (95% CI 1.17–3.90)], but not with age or lower eGFR at initiation. They were lower in patients with planned dialysis modality [0.46 (95% CI 0.19–1.10)] and more nephrologist visits in the 12 months before dialysis [0.81 (95% CI 0.70–0.94)] for each visit. Conclusions This study highlights several patient- and provider-level factors that are important to address to reduce the burden of urgent-start dialysis.
    Type of Medium: Online Resource
    ISSN: 0931-0509 , 1460-2385
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2021
    detail.hit.zdb_id: 1465709-0
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: Nephrology Dialysis Transplantation, Oxford University Press (OUP), ( 2023-11-03)
    Abstract: Trajectories of haemoglobin in patients with chronic kidney disease (CKD) have been poorly described. In such patients, we aimed to identify typical haemoglobin trajectory profiles and estimate their risks of major adverse cardiovascular events (MACE). Methods We used 5-year longitudinal data from the CKD-REIN cohort patients with moderate to severe CKD enrolled from 40 nationally representative nephrology clinics in France. A joint latent class model was used to estimate, in different classes of haemoglobin trajectory, the competing risks of (i) MACE + defined as the first event among cardiovascular death, non-fatal myocardial infarction, stroke or hospitalization for acute heart failure, (ii) initiation of kidney replacement therapy (KRT), and (iii) non-cardiovascular death. Results During the follow-up, we gathered 33 874 haemoglobin measurements from 3 011 subjects (median, 10 per patient). We identified five distinct haemoglobin trajectory profiles. The predominant profile (n = 1885, 62.6%) showed an overall stable trajectory and low risks of events. The four other profiles had nonlinear declining trajectories: early strong decline (n = 257, 8.5%), late strong decline (n = 75, 2.5%), early moderate decline (n = 356, 11.8%) and late moderate decline (n = 438, 14.6%). The four profiles had different risks of MACE, while the risks of KRT and non-cardiovascular death consistently increased from the haemoglobin decline. Conclusion In this study, we observed that two third of patients had stable haemoglobin trajectory and low risks of adverse events. The other third had a nonlinear trajectory declining at different rates, with increased risks of events. A better attention to dynamic changes of haemoglobin in CKD should be paid.
    Type of Medium: Online Resource
    ISSN: 0931-0509 , 1460-2385
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2023
    detail.hit.zdb_id: 1465709-0
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    FapUNIFESP (SciELO) ; 2015
    In:  Revista da Escola de Enfermagem da USP Vol. 49, No. spe ( 2015-12), p. 101-108
    In: Revista da Escola de Enfermagem da USP, FapUNIFESP (SciELO), Vol. 49, No. spe ( 2015-12), p. 101-108
    Abstract: RESUMEN Objetivo Comparar pacientes hipertensivos con y sin enfermedad renal e identificar factores asociados relacionados a la condición clínica y tratamiento anti-hipertensivo. Método Estudio trasversal con pacientes en clínica médica de un hospital universitario de São Paulo. Los datos fueron recolectados mediante análisis de archivo. Valores de p 〈 0,05 fueron considerados significantes. Resultados De los 386 pacientes evaluados, 59,3% era hipertensivo y, entre estos, 37,5% sufría de enfermedad renal crónica. Fue encontrada asociación independiente de la presencia de enfermedad renal crónica para antecedentes de diabetes (OR 1,86; IC 1,02-3,41) y de insuficiencia cardíaca congestiva (OR 3,42; IC 1,36-9,03); además del hecho de vivir con pareja (OR 1,99; IC 1,09-3,69). Respecto al tratamiento anti-hipertensivo, fue encontrada diferencia (p 〈 0,05) entre los hipertensivos con y sin enfermedad renal respecto a hacer monitoreo de salud (93,2% vs 77,7%); uso continuo de medicamentos anti-hipertensivos, (79,1% vs 66,4%); mayor número de medicamentos anti-hipertensivos; uso de bloqueadores beta-adrenérgicos (34,9% vs 19,6%), bloqueadores de los canales de calcio (29,1% vs 11,2%), diuréticos de asa (30,2% vs 10,5%) y vasodilatadores (9,3%vs 2,1%). Conclusión Los hipertensivos con enfermedad renal crónica mostraron perfil clínico más comprometido pero, respecto al tratamiento anti-hipertensivo, las actitudes fueron más positivas que entre aquellos sin enfermedad renal.
    Type of Medium: Online Resource
    ISSN: 0080-6234
    Language: Unknown
    Publisher: FapUNIFESP (SciELO)
    Publication Date: 2015
    detail.hit.zdb_id: 2411320-7
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    FapUNIFESP (SciELO) ; 2017
    In:  Einstein (São Paulo) Vol. 15, No. 1 ( 2017-03), p. 45-49
    In: Einstein (São Paulo), FapUNIFESP (SciELO), Vol. 15, No. 1 ( 2017-03), p. 45-49
    Abstract: RESUMO Objetivo Caracterizar hipertensos após internação quanto a condição atual, adesão ao tratamento, hábitos e estilos de vida, e conhecimento e crenças sobre a doença. Métodos Estudo exploratório, com 265 hipertensos, após internação em clínica médica de hospital universitário. Os dados foram coletados em entrevista por contato telefônico. O nível de significância foi de p 〈 0,05. Resultados Verificou-se que 32% dos pacientes faleceram. Foram entrevistados 100 hipertensos, com média de idade de 64,15 (13,2) anos, 51% eram mulheres, 56% não brancos, 51% com 1o grau de escolaridade, 52% eram aposentados, 13% tabagistas, 38% usavam bebida alcoólica, 80% não realizavam exercícios físicos e o índice de massa corporal médio foi de 35,9 (15,5) kg/m2. As comorbidades foram problema cardíaco (52%), diabetes (49%) e acidente vascular encefálico (25%). Quanto ao tratamento anti-hipertensivo, 75% estavam em uso de medicamentos, 17,3% deixaram de tomá-los e 21,3% faltaram às consultas. O tratamento era feito em unidade básica de saúde (49%) e no hospital (36%). Quanto aos conhecimentos e crenças, 25% acreditavam que hipertensão tinha cura, 77% que o tratamento deveria ser por toda a vida e 84% que a hipertensão trazia complicações. Estavam controlados 46,7% hipertensos. A ausência de controle associou se com etnia não branca e ausência de problemas cardíacos (p 〈 0,05). Conclusão Foram expressivas as mortes ocorridas após internação e controle insatisfatório da pressão arterial, provavelmente decorrentes de hábitos e estilos de vida inadequados e não realização adequada do tratamento anti-hipertensivo.
    Type of Medium: Online Resource
    ISSN: 1679-4508
    Language: Unknown
    Publisher: FapUNIFESP (SciELO)
    Publication Date: 2017
    detail.hit.zdb_id: 2418293-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    In: Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 38, No. Supplement_1 ( 2023-06-14)
    Abstract: The transition to kidney failure is the period of the highest risk for adverse outcomes in chronic kidney disease (CKD). A smooth and timely transition of care, assuring informed and patient-centric decision-making, is paramount to fostering better kidney care. We described the two-year incidence of clinical outcomes and nephrology practices among advanced CKD patients in CKDopps. Method CKDopps is a prospective cohort study designed to describe and evaluate variations in CKD practices and outcomes in nephrologist-led CKD clinics. For this analysis, we included CKDopps participants who reached a three-month average estimated glomerular filtration rate (eGFR) of less than 20 mL/min/1.73 m2 in the US, France, and Brazil. Time at risk for outcomes started at the end of the first three-month window in which the average eGFR was lower than 20 mL/min/1.73 m2 during study follow-up. Education was defined as participation in at least one educational session about KRT modalities. They were considered to have been referred to vascular access (VA) creation if reported in medical records. Education or VA referral happening before the start of follow-up were classified as occurring at baseline. Patients were considered waitlisted if they had been registered on a pre-emptive kidney transplant waiting list. Cumulative incidence functions adjusting for the competing risk of mortality or KRT were used to estimate the 2-year probability of clinical outcomes and planning events. Results 2,645 patients were included – 51% from France, 36% from the US, and 14% from Brazil. Overall, 56% of patients were male, the mean age was 66 ± 14 years, approximately 50% had diabetes, 27% had coronary artery disease, and 16% had heart failure. Patients in Brazil tended to be younger (63 years) than those in France (67) and the US (67); patients in the US had the greatest burden of cardiovascular comorbidities. The mean eGFR at the study baseline was 16.6 mL/min/1.73m² (15.4 in Brazil, 15.9 in the US, and 17.3 in France). Over a median follow-up of 15.7 [7.2–24] months, 1140 patients (43.1%) started KRT, whereas 377 (14.3%) died before KRT. The 2-year cumulative incidence of KRT was 32% in Brazil, 33% in France, and 44% in the US (Figure 1). The median eGFR at KRT initiation was 11.7 in Brazil, 9.0 in France, and 10.3 in the US. Pre-KRT death risk in two years was 7.3% in Brazil, 10.9% in France, and 16.4% in the US. In two years, approximately one-third of patients had a VA created across countries (Table 1). The probability of transplant waitlisting was higher in France and the US, while patient-reported KRT education was more common in Brazil (Table 1). Conclusion In this international analysis of advanced CKD patients, we found important variations in nephrology practice and outcomes across countries. Patients in the US have a higher risk of both pre-KRT death and KRT. Patient-reported education was far more common in Brazil than in the US and France. Although patients in Brazil are referred for VA creation earlier in the course of advanced CKD, 2-year cumulative incidences for such are similar across countries. The 2-year probability of pre-emptive kidney transplant listing was higher in France and the US. Further international studies evaluating risk factors for adverse outcomes and barriers to KRT planning among advanced CKD patients are warranted.
    Type of Medium: Online Resource
    ISSN: 0931-0509 , 1460-2385
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2023
    detail.hit.zdb_id: 1465709-0
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2022
    In:  Journal of Hypertension Vol. 40, No. Suppl 1 ( 2022-06), p. e12-e13
    In: Journal of Hypertension, Ovid Technologies (Wolters Kluwer Health), Vol. 40, No. Suppl 1 ( 2022-06), p. e12-e13
    Type of Medium: Online Resource
    ISSN: 0263-6352 , 1473-5598
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2022
    detail.hit.zdb_id: 2017684-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    In: Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 38, No. Supplement_1 ( 2023-06-14)
    Abstract: Magnesium (Mg) is involved in a multitude of essential physiological processes. In chronic kidney disease (CKD), the mechanisms compensating for the decrease in glomerular filtration rate (eGFR) become insufficient and Mg excretion tends to decrease, potentially resulting in hypermagnesemia. On the other hand, hypomagnesemia seems also to be common in CKD, due to changes in Mg intake through diet, reduced absorption and drug-induced hypomagnesemia. To date, a few studies have shown an association between increased cardiovascular risk in CKD and either low or high total Mg levels. However, the physiologically active fraction of extracellular Mg is ionized Mg (iMg), which is not routinely measured. In critical ill patients, the correlation between iMg and total Mg has been shown to be poor. Similar data on patients with CKD would be important to future studies aiming at clarifying the link between Mg and outcomes, and ultimately to determine the interest of iMg assay in routine practice. The objectives of this study are i) to study the correlation between total Mg and iMg and ii) to evaluate the relation between serum ionized magnesemia, estimated GFR (eGFR) and demographic and biologic parameters. Method CKD-REIN is a French, prospective, nationally representative cohort study of 3033 CKD patients under nephrology care not receiving maintenance dialysis (stage 3-5: eGFR & lt;60 mL/min/1.73 m² based on 2009 CKD-EPI equation). Baseline iMg and total Mg serum concentrations were respectively centrally measured using the NOVA BIOMEDICAL Stat Profile PRIME ES analyser and with Atellica® CH SIEMENS analyser. Normal range of serum total Mg considered was 0.66 to 1.06 mmol/L (from Atellica®). Mean ± standard deviation (SD) ionized Mg level evaluated in a cohort of 457 healthy volunteers (age = 45 ± 17 years; eGFR = 72.3 ± 13 mL/min/1.73m²) was 0.49 ± 0.05 mmol/L (median [tertile 1 – tertile 3] = 0.49 [0.45-0.52] mmol/L). Correlation between iMg and total Mg was estimated overall. Multivariate linear regressions were performed to identify factors associated with iMg and total Mg levels. Results Among 1741 patients with iMg and total Mg at baseline, the median age was 68 years [59-76], 65% were men, and the mean eGFR was 35 ± 14 mL/min/1.73m². The mean baseline iMg level was 0.48 ± 0.1 mmol/L, 615 patients had an ionized Mg & lt;0.45 mmol/L (Tertile 1), 599 had an iMg between 0.46 and 0.52 mmol/L (Tertile 2), and 527 had an iMg & gt;0.52 mmol/L (Tertile 3). Compared to healthy volunteers, mean iMg levels were significantly lower in CKD patients. However, the difference was small (difference CKD-heatlhy = 0.01 mmol/L). Most of patients were within the total Mg normal range (n = 1522), 12% (n = 208) and 1% (n = 11) presented hypo- and hypermagnesemia, respectively. Correlation between iMg and total Mg was very high (r = 0.88; p & lt;0.001). (Figure). Ionized Mg was weakly inversely correlated with eGFR (r = -0.22; p & lt;0.001). Consequently, the mean iMg level differed according to CKD stages, being more elevated in the advanced stages (0.45 mmol/L in stages 2-3A; 0.47 mmol/L in stage 3B; 0.50 mmol/L in stages 4-5 (p & lt;0.001)). In a fully adjusted linear regression model, iMg concentration was significantly associated with age, decline of eGFR, history of cardiovascular disease and the use of diuretics, and inversely associated with calcium and triglycerides levels, systolic blood pressure, diabetes, and the use of proton pump inhibitors and potassium chelators. The same factors were associated with total Mg. Conclusion Total Mg and iMg were strongly correlated. Decline of kidney function was associated to an increase of iMg in patients with moderate-to-advanced CKD. Additional studies need to compare the difference between total Mg and iMg as a biomarker to predict hard outcomes.
    Type of Medium: Online Resource
    ISSN: 0931-0509 , 1460-2385
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2023
    detail.hit.zdb_id: 1465709-0
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    In: Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 38, No. Supplement_1 ( 2023-06-14)
    Abstract: Timely arteriovenous (AV) access creation in view of starting hemodialysis is challenged by non-linear kidney function decline and the prospect of competing mortality. In addition, some studies have shown slower CKD progression following AV access creation in patients not on dialysis. While pathophysiological mechanisms, such as ischemic preconditioning and improved kidney perfusion, have been put forward to explain the apparent influence of AV access creation on estimated glomerular filtration rate (eGFR) trajectory, it cannot be ruled out that this finding resulted from an artefact induced by the use of models assuming linear (eGFR) decline before and after AV access creation. Our aim was to describe the kinetics of eGFR decline around the period of AV access creation and to identify different trajectory profiles using models relaxing this hypothesis. Method From 2013 through 2016, the CKD-REIN cohort included 3033 patients with CKD stages 3 to 5 from 40 nationally representative outpatient nephrology clinics in France. Participants were followed for 5 years or until initiation of kidney replacement therapy (KRT), death, or loss to follow-up, whichever came first. This study focused on patients who underwent their first AV access creation during follow-up. Linear mixed models with restricted cubic spline functions (two internal knots, one at AV access creation date, the other, one year before) were used to model a potential non-linear eGFR trajectory over time, based on routine labs. Random effects for the intercept and the spline function components allowed us to deal with individual variations in eGFR trajectory. Instantaneous rates of eGFR decline around AV access creation were then extracted. In addition, we performed latent class mixed models (LCMM) to identify distinct eGFR trajectories. Results During a median follow-up of 5.0 years (interquartile range [IQR], 4.6 to 5.2), 415 (14% of the total population) patients underwent a first AV access creation (32% women, 51% with diabetes). The median age at AV access creation was 69 years (IQR, 61 to 76), and the median eGFR, 13 ml/min/1.73 m² (IQR, 11 to 16). The median numbers of eGFR measurements before and after creation were 12 (IQR, 8 to 19) and 3 (IQR, 2 to 6) respectively. The average eGFR decline in the year before and after AV access creation, assuming constant slopes in each period, was 5.2 ml/min/1.73m² (95% confidence interval [CI] , 4.8 to 5.5) and 3.4 ml/min/1.73 m² (95% CI, 3.1 to 3.7), respectively, with a mean difference of −1.8 ml/min/1.73m2 (95% CI, −1.4 to −2.1). Analysis of instantaneous rates showed that the slowdown of eGFR decline began 8.3 months on average (95% CI, 7.8 to 8.6) before AV access creation. The LCMM identified two profiles of eGFR trajectories which mostly differed in the rate of eGFR decline (Figure). In both trajectories, the mean time to the slowdown of eGFR decline preceded time of AV access creation, by 9.1 and 7.2 months in the fastest and slowest eGFR decline trajectories, respectively. Conclusion In nondialysis patients, slowdown of kidney function decline appears to occur several months before AV access creation. Our findings do not support a causal biological effect of AV access creation on CKD progression, but favor alternative hypotheses including optimal management before AV access creation, greater inaccuracy in eGFR estimation in advanced CKD due to muscle mass loss, or simply regression to the mean.
    Type of Medium: Online Resource
    ISSN: 0931-0509 , 1460-2385
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2023
    detail.hit.zdb_id: 1465709-0
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    In: Journal of the American Society of Nephrology, Ovid Technologies (Wolters Kluwer Health), Vol. 34, No. 11S ( 2023-11), p. 379-379
    Type of Medium: Online Resource
    ISSN: 1046-6673
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2023
    detail.hit.zdb_id: 2029124-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2023
    In:  Journal of the American Society of Nephrology Vol. 34, No. 11S ( 2023-11), p. 41-42
    In: Journal of the American Society of Nephrology, Ovid Technologies (Wolters Kluwer Health), Vol. 34, No. 11S ( 2023-11), p. 41-42
    Type of Medium: Online Resource
    ISSN: 1046-6673
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2023
    detail.hit.zdb_id: 2029124-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages